Merck initiates melanoma filing with FDA
January 13, 2014 at 11:45 AM EST
Merck has initiated a rolling submission of its Food and Drug Administration application for its treatment for patients with advanced melanoma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.